• Trials and Research

  Relapsing MS Patients May Fare Better on Zeposia Than Aubagio: Study

  Posted by MS News Today Moderator on May 28, 2021 at 9:06 am

  

  Relapsing MS patients have lower relapse risk, less disability progression, and fewer side effects with Zeposia than Aubagio, an indirect comparison study says. Click here to learn more.

  Do these findings surprise you? Why or why not?

  MS News Today Moderator replied 3 years, 11 months ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply